Literature DB >> 10484338

Endotoxin-mediated nitric oxide synthesis inhibits IL-1beta gene transcription in ANA-1 murine macrophages.

R A Schroeder1, C Cai, P C Kuo.   

Abstract

On the basis of previous work demonstrating nitric oxide (NO)-mediated inhibition of nuclear factor-kappaB (NF-kappaB) DNA binding, we hypothesized that NO downregulates NF-kappaB-dependent interleukin-1beta (IL-1beta) production in an ANA-1 macrophage model of lipopolysaccharide (LPS) stimulation. In the presence of LPS (100 ng/ml), levels of IL-1beta protein and mRNA were significantly upregulated with NO synthase inhibition. Using nuclear run-on analysis and transient transfection studies, IL-1beta gene transcription and IL-1beta promoter activity were also found to be increased with inhibition of NO production. Parallel transfection studies using an NF-kappaB long terminal repeat-reporter plasmid exhibited similar findings, suggesting an NO-mediated effect on NF-kappaB activity. Gel shift studies showed that LPS-associated NF-kappaB DNA binding was increased, both in the setting of NO synthase inhibition and in a reducing environment. Repletion of NO by addition of an S-nitrosothiol restored IL-1beta protein synthesis, mRNA levels, gene transcription, promoter activity, and NF-kappaB DNA binding to levels noted in the presence of LPS alone. Our studies indicate that NO may regulate LPS-associated inflammation by downregulating IL-1beta gene transcription through S-nitrosation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484338     DOI: 10.1152/ajpcell.1999.277.3.C523

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages.

Authors:  Y H Li; Z Q Yan; J S Jensen; K Tullus; A Brauner
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1beta-inducing ability.

Authors:  H Shimomura; M Matsuura; S Saito; Y Hirai; Y Isshiki; K Kawahara
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia.

Authors:  Raquel Ferreira; Sara Xapelli; Tiago Santos; Ana Paula Silva; Armando Cristóvão; Luísa Cortes; João O Malva
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 4.  Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome.

Authors:  Gerwyn Morris; Michael Berk; Hans Klein; Ken Walder; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

Review 5.  Can nitric oxide-based therapy prevent bronchopulmonary dysplasia?

Authors:  Thomas M Raffay; Richard J Martin; James D Reynolds
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

Review 6.  Protein S-nitrosylation in health and disease: a current perspective.

Authors:  Matthew W Foster; Douglas T Hess; Jonathan S Stamler
Journal:  Trends Mol Med       Date:  2009-08-31       Impact factor: 11.951

Review 7.  Redox regulation of the immune response.

Authors:  Gerwyn Morris; Maria Gevezova; Victoria Sarafian; Michael Maes
Journal:  Cell Mol Immunol       Date:  2022-09-02       Impact factor: 22.096

8.  Mechanism-based triarylphosphine-ester probes for capture of endogenous RSNOs.

Authors:  Uthpala Seneviratne; Luiz C Godoy; John S Wishnok; Gerald N Wogan; Steven R Tannenbaum
Journal:  J Am Chem Soc       Date:  2013-05-08       Impact factor: 15.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.